Millions of Americans rely on daily blood pressure medication to keep their numbers in check and support heart health every single day. But imagine opening your medicine cabinet only to learn that nearly 600,000 bottles of a commonly prescribed drug have been pulled from shelves due to potential contamination with a substance linked to cancer risk. This recent recall has left many people feeling anxious about their prescriptions and wondering if their own bottles are affected. The good news is that clear, practical steps can help you protect your health right now, and we’ll walk through exactly what to check and do in the sections ahead.
Here’s the part that might surprise you: even if your specific medication isn’t part of this recall, understanding how these issues happen can help you stay one step ahead with any future prescriptions.
What Exactly Happened in This Blood Pressure Drug Recall?
In late October 2025, Teva Pharmaceuticals and distributor Amerisource Health Services issued a voluntary nationwide recall for more than 580,000 bottles of prazosin hydrochloride capsules. The FDA classified it as a Class II recall because testing showed elevated levels of nitrosamine impurities — chemicals that can form during manufacturing or storage and are considered potentially concerning with long-term exposure.
Prazosin is an alpha-blocker often used to help manage high blood pressure by relaxing blood vessels. It is also sometimes prescribed for other needs like certain symptoms related to PTSD. The recall affects specific lots in 1 mg, 2 mg, and 5 mg strengths, with expiration dates ranging into 2025 and 2026.
But here’s what matters most for you: not every bottle of blood pressure medication is involved, and not every person taking prazosin needs to panic. The FDA emphasizes that the risk from these low-level impurities is generally considered small, especially for short-term exposure. Still, the agency and manufacturers took action out of an abundance of caution to protect public health.
